TEACHERS ADVISORS, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2019$8,234,000
+89.3%
212,277
-0.7%
0.01%
+66.7%
Q4 2018$4,349,000
-77.5%
213,717
-49.2%
0.01%
-50.0%
Q3 2018$19,300,000
+93.8%
420,940
+150.0%
0.01%0.0%
Q2 2018$9,960,000
-14.7%
168,379
-1.9%
0.01%
-20.0%
Q1 2018$11,674,000
-27.9%
171,555
+4.7%
0.02%
-28.6%
Q4 2017$16,195,000
-24.0%
163,837
-8.0%
0.02%
-27.6%
Q3 2017$21,319,000
+59.5%
178,027
+16.4%
0.03%
+52.6%
Q2 2017$13,363,000
+147.4%
152,898
+5.3%
0.02%
+137.5%
Q1 2017$5,401,000
+23.6%
145,197
+2.0%
0.01%
+14.3%
Q4 2016$4,371,000
-51.6%
142,373
+5.7%
0.01%
-53.3%
Q3 2016$9,029,000
+150.1%
134,654
+11.1%
0.02%
+150.0%
Q2 2016$3,610,000
+536.7%
121,192
+527.4%
0.01%
+500.0%
Q1 2016$567,000
-89.3%
19,317
-71.5%
0.00%
-90.0%
Q4 2015$5,320,000
+3.6%
67,860
-0.4%
0.01%0.0%
Q3 2015$5,133,000
-34.2%
68,113
+1.9%
0.01%
-33.3%
Q2 2015$7,806,000
-59.7%
66,861
-18.4%
0.02%
-58.3%
Q1 2015$19,353,000
+29.9%
81,965
+4.1%
0.04%
+24.1%
Q4 2014$14,903,000
-21.1%
78,741
-0.6%
0.03%
-23.7%
Q3 2014$18,890,000
+239.4%
79,179
-6.1%
0.04%
+245.5%
Q2 2014$5,565,000
-14.7%
84,314
+34.5%
0.01%
-21.4%
Q1 2014$6,527,000
+99.4%
62,673
+98.3%
0.01%
+100.0%
Q4 2013$3,273,000
+98.7%
31,612
+3.0%
0.01%
+75.0%
Q3 2013$1,647,000
+30.8%
30,702
+8.2%
0.00%
+33.3%
Q2 2013$1,259,00028,3670.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders